Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

$$$$Elite's Multi-Billion Dollar PipeLine: $$$$
UPDATE COMING
More approvals imminent

Short to mid term products are entering an IMS market value
of $6 + Billion Dollar$

Elite working multiple ADF opiods concurrently

$ Launched Generic Products $$$$

1. Hydromorphone Hydrochloride non-AD
8 mg Tablets
Dilaudid®
Pain

2. Naltrexone Hydrochloride
50 mg Tablets
Revia®
Opioid Antagonist

3. Phentermine HCl
37.5 mg Tablets
Adipex-P®
Bariatric

4. Phentermine HCI
15 mg and 30 mg Capsules
Adipex-P®
Bariatric

5.TWO * Phendimetrazine Tartrate One To make money, one to divest
35 mg Tablets, USP
Bontril®
Bariatric

6. Isradipine
2.5 mg and 5 mg Capsules
N/A
Cardiovascular

7. Hydroxyzine HCI
10 mg, 25 mg, 50 mg Tablets
Atarax®, Vistaril®
Antihistamine

8. Dantrolene Sodium
25 mg, 50 mg and 100 mg Capsules *
Dantrium®
Skeletal Muscle Relaxant

9. Loxapine
5 mg, 10 mg, 25 mg, 50 mg Capsules *
N/A
Antipsychotic

10. Additional Approved ANDA's *
Undisclosed
Undisclosed
* pending manufacturing site transfer

11. Trimipramine

$ BRANDED PRODUCTS $$$$

12. Lodrane D®
OTC Allergy
Valeant Pharmaceuticals International, Inc.


$ CONTRACT MANUFACTURING $$$$

13. Methadone Hydrochloride
10 mg Tablets
Dolophine®
Pain
Ascend Laboratories, LLC


$ GENERIC PIPELINE $$$$

14. ELI-300 Opioid
Undisclosed
Pain
Early Development

15. ELI-301 Opioid
Undisclosed
Pain
Early Development

16. Oxycodone HCl and Acetaminophen, USP 325 mg
5 mg, 7.5 mg, 10 mg Tablets
Percocet
Pain
Filed Pending FDA Approval

17. Hydrocodone and Acetaminophine tablet
2.5mg/325mg, 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets
Norco
Pain
Filed Pending FDA Approval

18. Elite/SunGen Generic #1
Undisclosed
CNS Stimulant
In Development

19. Elite/SunGen Generic #2
Undisclosed
CNS Stimulant
In Development

20. Elite/SunGen Generic #3
Undisclosed
Beta-Blocker
In Development

21. Elite/SunGen Generic #4
Undisclosed
Beta-Blocker
In Development

22. Elite/SunGen Generic #5
Undisclosed
Anti-depressant
In Development

23. Elite/SunGen Generic #6
Undisclosed
Antibiotic #1
In Development

24. Elite/SunGen Generic #7
Undisclosed
Antibiotic #2
In Development

25. Elite/SunGen Generic #8
Undisclosed
Antispasmodic
In Development

26. ELI-201 Generic ER Opioid
Troxyca equivalent
Pain
Waiting for Troxyca to launch to use as a comparator

27. Generic Embeda
Needs to be filed ASAP may be undisclosed
Pain

28. Generic ADF OxyContin
Filed pending approval
Pain

29. Generic Opana Oxymorphone
Pain


$ BRANDED PIPELINE $$$$

Development Stage
Partner

30. $equestOx™ (ELI-200) IR Opioid
Pain Filed with FDA
Being reformulated to decrease fed Tmax

31. IR ADF (2 bead) Hydrocodone

32. IR ADF (2 bead) Oxymorphone

33. IR ADF (2 bead) Hydromorphone

34. ELI-202 Opioid
Pain
Pivotal Bio-equivalence

35. ELI-216 Opioid ER 24hr (once/day)
Pain
Process Development

36. ELI-400 Opioid
Pain
Process Development

37. ELI-500 Opioid
Pain
Process Development

38. ELI-501 Opioid
Pain
Early Development

39. ELI-600 Opioid
Pain
Process development ELTP

Chinese ADF opiod one or more of the above

Canadian ADF opiod one or more of the above

European ADF opiod one or more of the above

$ ELTP $